Cargando…

Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal squamous cell carcinoma (ESCC) is a deadly disease for which no effective targeted therapeutic agent has been approved. Both AXL and c-MET have been reported to be independent prognostic factors for ESCC. Thus, inhibitors of AXL/c-MET might have great potential as targeted therapy for ESC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Pei-Wen, Liu, Yu-Cheng, Chang, Ya-Han, Lin, Ching-Ching, Huang, Pei-Ming, Hua, Kuo-Tai, Lee, Jang-Ming, Hsieh, Min-Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851194/ https://www.ncbi.nlm.nih.gov/pubmed/31781483 http://dx.doi.org/10.3389/fonc.2019.01138

Ejemplares similares

The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
por: Fleuren, Emmy D.G., et al.
Publicado: (2014)

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
por: Wakelee, Heather A., et al.
Publicado: (2017)

Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas
por: O'Sullivan Coyne, Geraldine, et al.
Publicado: (2022)

Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
por: Oien, Derek B., et al.
Publicado: (2018)

High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
por: Lin, Cheng-Han, et al.
Publicado: (2019)

The genetic effect and molecular function of the SOCS5 in the prognosis of esophageal squamous cell carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2021)

MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6
por: Wei, Lei, et al.
Publicado: (2020)

Genetic Variants of EGF and VEGF Predict Prognosis of Patients with Advanced Esophageal Squamous Cell Carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2014)

ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma
por: Tungekar, Asna, et al.
Publicado: (2018)

Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
por: Wang, Yang, et al.
Publicado: (2013)

Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
por: Essack, Magbubah, et al.
Publicado: (2012)

Allgemeiner Teil des BGB: ein Lehrbuch
por: Medicus, Dieter
Publicado: (1994)

Polymorphisms in the ERCC5 Gene and Risk of Esophageal Squamous Cell Carcinoma (ESCC) in Eastern Chinese Populations
por: Zhu, Mei-Ling, et al.
Publicado: (2012)

Correction: Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
Publicado: (2014)

The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC)
por: Li, Zhuang-hua, et al.
Publicado: (2016)

Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients
por: Zhang, Cui-Ying, et al.
Publicado: (2019)

Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells
por: Chen, Chuangui, et al.
Publicado: (2017)

Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2017)

The prognostic role of nutrition risk score (NRS) in patients with metastatic or recurrent esophageal squamous cell carcinoma (ESCC)
por: Zhou, Xia, et al.
Publicado: (2017)

CCGD-ESCC: A Comprehensive Database for Genetic Variants Associated with Esophageal Squamous Cell Carcinoma in Chinese Population
por: Peng, Linna, et al.
Publicado: (2018)

Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)
por: Zhao, Yue, et al.
Publicado: (2014)

Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model
por: Osei-Sarfo, Kwame, et al.
Publicado: (2015)

Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation
por: Li, Li-Yan, et al.
Publicado: (2015)

Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)
por: Pu, Weilin, et al.
Publicado: (2017)

Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2022)

Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK
por: Wang, Jia-Lin, et al.
Publicado: (2023)

The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma
por: Hsieh, Min-Shu, et al.
Publicado: (2016)

428 después de Cristo : historia de un año /
por: Traina, Giusto, 1959-
Publicado: (2011)

Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2021)

Local Liver Irradiation Concurrently Versus Sequentially with Cabozantinib on the Pharmacokinetics and Biodistribution in Rats
por: Huang, Yu-Chuen, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Experience
por: Kao, Ming-Wei, et al.
Publicado: (2023)

Entscheidungsbefugnis fur die Durchführung einer Schutzimpfung nach 1628 BGB – kein medizinisches Sachverständigengutachten zur Frage der Impffähigkeit erforderlich: BGB 1628, 1697a
Publicado: (2022)

Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis
por: Yang, Howard, et al.
Publicado: (2020)

Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)
por: Wang, Jian, et al.
Publicado: (2021)

Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2021)

A153 PYCRL LACTYLATION AS A POTENTIAL REGULATOR OF CANCER STEM CELL METABOLISM IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
por: Douchin, J, et al.
Publicado: (2023)

Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume
por: Cui, Tiantian, et al.
Publicado: (2021)

HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC)
por: Yang, Ju, et al.
Publicado: (2014)

Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagy
por: Xia, Di, et al.
Publicado: (2020)

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
por: Song, Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t2bjmi8r40dd67229jub1h4f1j